☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
quizartinib
Daiichi Sankyo Presents Results of Quizartinib in P-III (QuANTUM-First) Study for the Treatment of FLT3-ITD Positive Acute Myeloid...
June 13, 2022
Load more...
Back to Home
Modal title
×
Modal body text goes here.